InhaleRx Limited

Equities

IRX

AU0000179475

Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 07:10:38 17/05/2024 BST			5-day change	1st Jan Change
0.04 ^AUD	0.00%		0.00%	+37.93%

03-28	InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	CI
02-14	InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

InhaleRx Limited Announces Executive Changes

August 03, 2023 at 12:36 am

InhaleRx Limited announced the appointment of James Barrie as Company Secretary effective from August 3, 2023. Mr. Barrie is a professional Company Secretary and Director, and the Board welcomes his input moving forward. Elizabeth Spooner and Nova Taylor of Automic Group will step down as Joint Company Secretaries effective 3 August 2023.

The Board would like to acknowledge the contribution of Elizabeth Spooner and Nova Taylor during their tenure. James Barrie will be the person responsible for communications between the Company and ASX.

Latest news about InhaleRx Limited

InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	03-27	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
InhaleRx to Focus on Breakthrough Cancer Pain for Phase 2 Trial of Cannabinoid Analgesic	01-10	MT
InhaleRx Secures Nearly AU$550,000 R&D tax Incentive Prepayment	12-21	MT
InhaleRX Completes Phase One Trial for Pain Medication Device	12-04	MT
InhaleRx Files Ethics Application for Panic Disorder Trial	18/10/23	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23	CI
InhaleRx Limited Announces Change of Registered Office Address	03/08/23	CI
InhaleRx Limited Announces Executive Changes	03/08/23	CI
InhaleRx Completes First Cohort of Phase One Clinical Trial	14/06/23	MT
Australian Shares Retreat Anew on Rate Hike, Slower-than-Expected GDP Growth	07/06/23	MT
InhaleRx Doses First Individuals for Phase One Trial of Inhalable Pain Medication	07/06/23	MT
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	29/03/23	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	26/02/23	CI
InhaleRx Hires Contract Research Organization for Upcoming Clinical Trials	22/12/22	MT
Inhalerx Limited Announces Fda Pre-Ind Application Update	11/12/22	CI
InhaleRx Limited Announces Board and Management Changes	27/09/22	CI
InhaleRx Limited Announces the Appointment of Darryl Davies as Chief Executive Officer	27/09/22	CI
InhaleRx Raises $810,000 From Share Placement	19/09/22	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22	CI
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	30/03/22	CI
InhaleRx Secures Licenses to Sell, Supply Controlled Substances	30/03/22	MT
Victorian Department of Health & Human Services Grants Wholesale Licenses to Inhalerx Limited to Sell and Supply Poisons or Controlled Substances	29/03/22	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2021	27/02/22	CI
InhaleRx Ltd Appoints Darryl Davies as Executive Director	28/12/21	CI

Chart InhaleRx Limited

Duration

Period

More charts

Company Profile

Inhalerx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. The Company partners with educators in their technical and therapeutic fields, to provide inhalation therapies that deliver added value for patients, doctors, business partners, governments, and stakeholders alike. Its Medihale Inhaler is a sealed pod inhaler designed specifically for use with inhaled formulations. It utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material. The sealed tamper-proof Medihale Pods provide patients with additional security. The Medihale Protective Charging Case automatically recharges the Medihale Inhaler when the inhaler is returned to its case. The Medihale Protective Charging Case even has a dedicated storage space to carry an extra Medihale c-liquid Pod.

Sector

Advanced Medical Equipment & Technology

Calendar

30/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INHALERX LIMITED	+37.93%	5.07M
THERMO FISHER SCIENTIFIC	+11.18%	227B
DANAHER CORPORATION	+15.22%	198B
INTUITIVE SURGICAL, INC.	+19.19%	142B
BOSTON SCIENTIFIC CORPORATION	+30.89%	111B
SIEMENS HEALTHINEERS AG	+1.56%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+18.48%	54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.12%	51.41B
AGILENT TECHNOLOGIES, INC.	+10.53%	45.32B
GE HEALTHCARE TECHNOLOGIES INC.	+5.98%	37.32B

Other Advanced Medical Equipment & Technology